Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Population-level impact of mass drug administration against schistosomiasis with anthelmintic drugs targeting juvenile schistosomes: a modelling study

The Lancet Microbe(2025)10.1016/j.lanmic.2024.101065Source: DataRank Database

Population-level impact of mass drug administration against schistosomiasis with anthelmintic drugs targeting juvenile schistosomes: a modelling study is a research paper published in The Lancet Microbe (2025). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 7.56)OA: goldTopics (75)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Mireille Gomes ORCID,Jean T. Coulibaly ORCID,Minoli Daigavane,Sophia T. Tan ORCID,Isaac I. Bogoch ORCID

Live enrichment

PubMed:40412412 PMC:PMC12244469 OpenAlex:https://openalex.org/W4410577616

National Institute of Allergy and Infectious Diseases

Grant: R01AI179771

National Institutes of Health

Grant: 5R01AI179771-02

Precision mapping of Schistosoma mansoni risk for targeted public health control and elimination

National Institutes of Health

University Health Network

FWCI

7.56

Citation Percentile

1.0%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://www.thelancet.com/action/showPdf?pii=S2666524724003331

publisherhttps://www.thelancet.com/action/showPdf?pii=S2666524724003331

publisherhttps://api.elsevier.com/content/article/PII:S2666524724003331?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666524724003331?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.lanmic.2024.101065

Fields of Study

Parasites and Host InteractionsParasite Biology and Host InteractionsHelminth infection and control03 medical and health sciences0303 health sciencesAnimalsMass Drug AdministrationAnthelminticsSchistosoma mansoniPraziquantelHumansSchistosomiasis mansoniMaleFemaleAdultSchistosomiasis

MeSH Terms

Mass Drug AdministrationAdultAnimalsAnthelminticsFemaleHumansMalePraziquantelSchistosoma mansoniSchistosomiasisSchistosomiasis mansoni

Keywords

AnthelminticMass drug administrationJuvenileSchistosomiasisDrugMedicinePopulationPharmacologyImmunologyBiologyHelminthsEnvironmental healthVeterinary medicineEcologyMaleAdultSchistosoma mansoni (mesh)Schistosomiasis mansoni (mesh)ArticlePraziquantelRare Diseases (rcdc)Anthelmintics (mesh)5.1 Pharmaceuticals (hrcs-rac)Mass Drug Administration (mesh)Animals (mesh)AnimalsHumans3207 Medical Microbiology (for-2020)32 Biomedical and Clinical Sciences (for-2020)Male (mesh)3204 Immunology (for-2020)Pediatric (rcdc)Praziquantel (mesh)AnthelminticsHumans (mesh)3 Good Health and Well Being (sdg)3107 Microbiology (for-2020)Vector-Borne Diseases (rcdc)Schistosoma mansoniSchistosomiasis mansoniInfection (hrcs-hc)Infectious Diseases (rcdc)Female (mesh)Orphan Drug (rcdc)Adult (mesh)FemaleSchistosomiasis (mesh)Digestive Diseases (rcdc)